Your session is about to expire
← Back to Search
DPP for Diabetes (CDPP Trial)
N/A
Waitlist Available
Research Sponsored by LMC Diabetes & Endocrinology Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months and 12 months
Awards & highlights
CDPP Trial Summary
This trial found 5.7 million Canadians have prediabetes and could develop Type 2 Diabetes; diet and exercise can reduce the risk.
Eligible Conditions
- Diabetes
CDPP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
> 3% and ≥ 5% reduction in waist circumference
A1c at final visit <6.5% measured by lab test
BMI < 25.0 and/or weight loss ≥ 5.0%
+3 moreSecondary outcome measures
Change in HDL
Change in LDL-c and non-HDL (subgroup analyses for people on cholesterol lowering medications vs. no cholesterol lowering medications during the project)
Change in blood pressure
+17 moreOther outcome measures
Issues with delivery by service providers
Level of participant engagement
Objective scoring of program coach audits
+2 moreCDPP Trial Design
1Treatment groups
Experimental Treatment
Group I: DPPExperimental Treatment1 Intervention
The CDC Diabetes Prevention Program (DPP) curriculum for lifestyle intervention, including 21 education topics delivered via text-based education module, and follow-up telephone health coaching call for each topic.
Find a Location
Who is running the clinical trial?
LMC Diabetes & Endocrinology Ltd.Lead Sponsor
16 Previous Clinical Trials
20,709 Total Patients Enrolled
Public Health Agency of Canada (PHAC)OTHER_GOV
45 Previous Clinical Trials
94,959 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are taking medication to lower your blood sugar levels.You have access to telephone and internet services from a variety of sources, such as your home, workplace, friend's residence, relative's abode or public library.You have been diagnosed with prediabetes and meet the criteria of having an A1c level between 6.0-6.4% or a fasting glucose level in the range of 6.1-6.9 mmol/L, and you are at least 18 years old.You are taking medication for weight loss.You achieved a score of 33 or higher on the Canadian Diabetes Risk Assessment (CANRISK) Questionnaire (applicable to those aged 18-74).You have taken or plan to take steroids by mouth or injection within the last three months, but inhalers or nasal sprays are allowed.
Research Study Groups:
This trial has the following groups:- Group 1: DPP
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it currently possible to enter this clinical investigation?
"Clinicialtrials.gov confirms that this clinical trial is no longer seeking patients, with the original posting date being June 21st 2019 and the last update occurring on March 14th 2023. Fortunately, there are currently 1,415 other experimental studies actively recruiting individuals to participate in their research."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger